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Simple Summary: The physiological functions of proteins are destined by their unique three-
dimensional structures. Almost all biological kingdoms share conserved disulfide-catalysts and
chaperone networks that assist in correct protein folding and prevent aggregation. Disruption of these
networks is implicated in pathogenesis, including neurodegenerative disease. In the mammalian
endoplasmic reticulum (ER), more than 20 members of the protein disulfide isomerase family (PDIs)
are believed to cooperate in the client folding pathway, but it remains unclear whether complex
formation among PDIs via non-covalent interaction is involved in regulating their enzymatic and
chaperone functions. Herein, we report novel functional hetero complexes between PDIs that promote
oxidative folding and inhibit aggregation along client folding. The findings provide insight into the
physiological significance of disulfide-catalyst and chaperone networks and clues for understanding
pathogenesis associated with disruption of the networks.
Abstract: P5 is one of protein disulfide isomerase family proteins (PDIs) involved in endoplasmic
reticulum (ER) protein quality control that assists oxidative folding, inhibits protein aggregation, and
regulates the unfolded protein response. P5 reportedly interacts with other PDIs via intermolecular
disulfide bonds in cultured cells, but it remains unclear whether complex formation between P5 and
other PDIs is involved in regulating enzymatic and chaperone functions. Herein, we established the
far-western blot method to detect non-covalent interactions between P5 and other PDIs and found
that PDI and ERp72 are partner proteins of P5. The enzymatic activity of P5-mediated oxidative
folding is up-regulated by PDI, while the chaperone activity of P5 is stimulated by ERp72. These
findings shed light on the mechanism by which the complex formations among PDIs drive to
synergistically accelerate protein folding and prevents aggregation. This knowledge has implications
for understanding misfolding-related pathology.
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1. Introduction
Numerous amount of secretory and membrane proteins that are inserted into the
mammalian endoplasmic reticulum (ER) must undergo disulfide bond formation-coupled
protein folding, oxidative folding, to form unique functional three-dimensional struc-
tures [1–3]. Non-native disulfide-bonded misfolded proteins frequently lead to the forma-
tion of aggregates [4–7]. To reduce the risk of accumulation of aberrant proteins, almost all
biological kingdoms have evolved both disulfide-catalyst and chaperone networks that as-
sist proper folding [8–10]. Correspondingly, more than 20 members of the protein disulfide
isomerase family (PDIs), e.g., PDI, ERp57, ERp72, ERp46, and P5, and other ER-resident
chaperones constitute a protein homeostasis network that catalyzes oxidative folding and
inhibits aggregation to ensure proper protein production in the mammalian ER [11–15].
Thus, mutation or unfavorable post-translational modification of PDIs is associated with
misfolding diseases, such as amyotrophic lateral sclerosis, Alzheimer’s disease, Parkin-
son’s disease, and prion disease [16–20]. Although many researchers have vigorously
investigated the disulfide-catalyst and molecular chaperone activities of PDI [21–30], the
underlying mechanism of how other PDIs modulate the assistance of oxidative folding and
the inhibition of client aggregation remains unclear [31].
Some substrates and enzymes that modulate PDI functions have been reported.
Unfolded substrate-induced PDI homo-dimerization enhances the ability of disulfide-
introduction into substrates [32]. Additionally, the α-subunit of prolyl 4-hydroxylase
(P4HA)-bound PDI (also known as P4HB) is involved in procollagen maturation pro-
cess [33,34]. Similarly, PDI complexed with the α-subunit of microsomal triglyceride trans-
fer protein functions as a lipid transfer machine [12,35]. These examples demonstrate that
the activities and functions of PDIs are regulated by forming homo- and hetero-complexes.
Like PDI, P5 (also known as ERp5 or PDIA6) is one of PDIs involved in ER protein qual-
ity control that assists oxidative folding [13,14,36–38], inhibits protein aggregation [36,37],
and regulates the ER stress response [16,36,39–41]. P5 consists of three thioredoxin (Trx)-
like domains (Figure 1a) [11,16] and dimerizes via a unique leucine-valine adhesive motif
contained in the N-terminal Trx-like domain [36]. This motif is involved in the regulation
of its chaperone activity and the regulation of intermolecular disulfide bonds in the ER
stress sensor IRE1 [36]. In addition, P5 reportedly interacts with other PDIs (PDI, ERp57,
ERp72, and ERp46) via intermolecular disulfide bonds in cultured cells [42], suggesting
that P5 and partner proteins may work cooperatively to catalyze oxidative folding in the
ER. Despite this progress, it remains unclear whether complex formation between P5 and
these PDIs is involved in the regulation of enzymatic and chaperone functions.
In this study, we performed comprehensive protein-protein interaction analysis using
the far-western dot blot method and identified PDI and ERp72 as partner proteins of P5
that interact via non-covalent interactions. We also found that P5 cooperates with PDI to
synergistically accelerate oxidative folding, while P5 cooperates with ERp72 to enhance
chaperone activity. These results provide new insights into the functional significance of
heterogeneous non-covalent complexes between PDIs that control protein homeostasis in
the mammalian ER.




Figure 1. PDI and ERp72 are partner proteins of P5 that interact via non-covalent complex for-
mation. (a) P5 structure [36]. P5 forms a dimer via the a0 domain (the first Trx-like domain). (b,c) 
Far-western dot blot analysis of non-covalent interactions between P5 and IRE1. Prey proteins, lac-
toferrin, albumin (negative control), IRE1 (positive control), and PDIs were dotted onto nitrocellu-
lose membranes. As a control, bait protein (P5) was also dotted onto the bottom lane of the same 
membranes. Blocked membranes were incubated in P5 bait buffer, and bound P5 was detected using 
anti-P5 antisera. (d) Quantification of chemiluminescence signals in (c). The amount of P5 bound to 
PDIs on membranes was calculated from three independent experiments, compared with the signal 
intensities of control dots of P5 (bottom lane). Data are presented as means ± standard error of the 
mean (SEM). (e,f) Binding isotherms for titration of P5 against PDI (e) and ERp72 (f). Catalytically-
inactive P5 (Cys55/58/190/193Ala) mutant (280 μM) in the syringe was titrated into 40 μM PDI or 40 
μM ERp72 in the cell. 
2. Materials and Methods 
2.1. Antibodies and Reagents 
Rabbit anti-P5 antiserum was prepared using recombinant P5. Antibodies were from 
the following sources: anti-rabbit (Cat. No. 711-035-152; Jackson ImmunoResearch Labor-
atories, West Grove, PA, USA); bovine serum albumin (Cat. No. A7638; Sigma-Aldrich, 
St. Louis, MO, USA); bovine milk lactoferrin (Cat. No. 123-04124; Fujifilm Wako Pure 
Chemical, Osaka, Japan); bovine pancreas ribonuclease (RNase A; Cat. No. R5500; Sigma-
Figure 1. PDI and ERp72 are partner proteins of P5 that interact via non-covalent complex formation. (a) P5 structure [36]. P5
forms a dimer via the a0 domain (the first Trx-like domain). (b,c) Far-western do blot analysis of n n-covalent interactions
between P5 nd IRE1. Prey proteins, lactoferrin, bumin (negative control), IRE1 (positiv control), and PDIs were
dotted onto nitrocellulose membranes. As a control, bait protein (P5) was also dotted onto the bottom lane of the same
membranes. Blocked membranes were incubated in P5 bait buffer, and bound P5 was detected using anti-P5 antisera.
(d) Quantification of chemiluminescence signals in (c). The amount of P5 bound to PDIs on membranes was calculated
from three independent experiments, compared with the signal intensities of control dots of P5 (bottom lane). Data are
presented as means ± standard error of the mean (SEM). (e,f) Binding isotherms for titration of P5 against PDI (e) and
ERp72 (f). Catalytically-inactive P5 (Cys55/58/190/193Ala) mutant (280 µM) in the syringe was titrated into 40 µM PDI or
40 µM ERp72 in the cell.
2. Materials and Methods
2.1. Antibodies and Reagents
R bbit anti-P5 antiserum was prepared using recombinant P5. Antibodies were
from the following sources: anti-rabbit (Cat. No. 711-035-152; Jackson ImmunoResearch
Laboratories, West Grove, PA, USA); bovine serum albumin (Cat. No. A7638; Sigma-
Aldrich, St. Louis, MO, USA); bovine milk lactoferrin (Cat. No. 123-04124; Fujifilm Wako
Pure Chemical, Osaka, Japan); bovine pancreas ribonuclease (RNase A; Cat. No. R5500;
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Sigma-Aldrich); Glyceraldehyde-3-phosphate Dehydrogenase from rabbit muscle (GAPDH;
Cat. No. G2267; Sigma-Aldrich).
2.2. Plasmid Construction
The human P5 (Lys20–Leu440) and ERp57 (Ser25–Leu481) genes cloned into pET15b
were a kind gift from Dr. Masakazu Kikuchi (Ritsumeikan University). The human PDI
(Asp18–Leu508), ERp46 (Arg33–Leu432), and ERp72 (Glu25–Leu645) genes were cloned
into pET15b, as previously described [14,43]. The human IRE1 (Ser24–Thr446) gene was
cloned into pGEX6p-1, as previously described [36].
2.3. Recombinant Protein Expression and Purification
The 6× His-tagged PDIs and mutated P5 were overexpressed in Escherichia coli strain
BL21 (DE3) and purified. Expression of recombinant proteins was induced by the addition
of 0.5 mM isopropyl-β-D-thiogalactopyranoside and culturing at 20 ◦C overnight. Cells
were disrupted by a Branson SFX250 Digital Sonifier homogenizer (Branson Ultrasonics,
Danbury, CT, USA) in buffer containing 50 mM Tris-HCl (pH 8.0) and 0.3 M NaCl. After
clarification of the cell lysate by centrifugation (20,000× g for 20 min), the supernatant
was purified by Ni-NTA column chromatography (Qiagen, Hilden, Germany), followed
by digestion with Thrombin Protease (Cat. No. 33842-44; Nacalai Tesque, Kyoto, Japan)
and 10 mM dithiothreitol treatment and then further purification by RESOURCE Q 6 mL
column chromatography (GE Healthcare Life Science, Uppsala, Sweden). Finally, the
sample was purified by Superdex 200 increase 10/300 GL column chromatography (GE
Healthcare Life Science) pre-equilibrated with buffer containing 50 mM HEPES (pH 7.2)
and 150 mM NaCl.
C-terminal Glutathione S-transferase (GST) and 6× His-tagged IRE1α LD was overex-
pressed in E. coli strain BL21 (DE3) and purified. Expression of recombinant proteins was
induced by addition of 0.5 mM isopropyl-β-D-thiogalactopyranoside and culturing at 15 ◦C
overnight. Cells were disrupted by an NS1001L 2K homogenizer (Niro Soavi, Parma, Italy)
in buffer containing 25 mM HEPES (pH 7.2), 25 mM L-arginine, 30 mM NaCl, and 10%
(w/v) glycerol. After clarification of the cell lysate by centrifugation (18,000× g for 30 min),
the supernatant was purified by Glutathione Sepharose 4B column chromatography (GE
Healthcare Life Science), followed by digestion with PreScission Protease (GE Healthcare
Life Science). The GST and 6× His-tag fusions were removed from digested IRE1α LD us-
ing Ni-NTA resin and further purification by RESOURCE Q 6 mL column chromatography
(GE Healthcare Life Science). Finally, the sample was purified by Superdex 200 increase
10/300 GL column chromatography (GE Healthcare Life Science) pre-equilibrated with
buffer containing 25 mM HEPES (pH 7.2), 25 mM L-arginine, and 150 mM NaCl.
2.4. Far-Western Dot Blotting
Far-western dot blot analyses were performed by optimizing the method reported in
previous studies [44,45]. Reduced purified protein solutions (40 µM) were diluted to an
appropriate concentration, and a 3 µL aliquot was dotted onto a ClearTrans nitrocellulose
membrane (Cat. No. 037-25653; Fujifilm Wako Pure Chemical, Osaka, Japan) as prey
protein. As a control experiment to estimate the amount of bound bait protein (P5), reduced
bait protein (0.5 µM) was dotted onto the bottom lane of the same membrane in the amounts
shown in Figure 1b,c. The membrane was blocked with 20 mM Tris-HCl (pH 7.6) containing
150 mM NaCl, 0.05% Tween 20, and 5% (w/v) skim milk (5% MTBST) at 4 ◦C for 1 h and then
incubated in 0.2 µM of reduced P5 as bait protein in 20 mM Tris-HCl (pH 7.6) containing
150 mM NaCl and 0.05% Tween 20 (TBST) at 4 ◦C for 3 h. The membrane was washed three
times with TBST and incubated with anti-P5 antiserum (1:10,000 in 1% MTBST). Next, the
membrane was washed three times with TBST and incubated with horseradish peroxidase-
conjugated anti-rabbit secondary antibody (1:10,000 in 1% MTBST). The membrane was
washed four times with TBST, and signals were visualized using Chemi-Lumi One Super
(Nacalai Tesque). Luminescence images were obtained by a LAS 4000 mini-instrument
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(Fuji Film), and relative signal intensities were quantified compared with signals of bait
control protein (Figure 1c, P5) with ImageJ/Fiji [46], Microsoft Excel (Microsoft, Roselle, IL,
USA), and GraphPad Prism 6.07 (GraphPad Software, Inc., La Jolla, CA, USA). The amount
of P5 bound to prey proteins was calculated from the relative signal intensities according
to the calibration curve obtained from the signals of bait control protein (P5).
2.5. Isothermal Titration Calorimetry
Isothermal titration calorimetry (ITC) measurements of PDIs complex formation were
carried out with 40 µM PDIs dissolved in 50 mM HEPES (pH 7.2) using a MicroCal Auto-
iTC200 instrument (Malvern Panalytical, Malvern, UK) with continuous stirring at 750 rpm.
Next, 110 µL of 50 mM HEPES (pH 7.2) and 150 mM NaCl solution containing 280 µM of
the P5 Cys55/58/190/193Ala mutant in the syringe were consecutively injected into the
PDIs solution in the cell after a 60 s initial delay for thermal equilibration. The total number
of titrations was 19 and the titration interval was 150 s. The initial delay and reference
power were set to 60 s and 10 µcal·s−1, respectively. The first titration was conducted using
0.4 µL of solution, and the remaining titrations was 2 µL in the syringe. Changes in the
heat flow were observed in real time at 10 µcal s−1 reference power and 30 ◦C. The dilution
heat of P5 Cys55/58/190/193Ala mutant was also measured using the same method and
the ITC parameters. The binding isotherms after the subtraction of dilution heat and the
baseline correction were fitted to one set of site binding model incorporated in the MicroCal










1 + [P5 Cys55/58/190/193Ala]tn[PDIs]t
+ Kdn[PDIs]t
)2
− 4[P5 Cys55/58/190/193Ala]tn[PDIs]t ]
where Q is the total heat constant and n indicates the number of P5 Cys55/58/190/193Ala
mutant molecules, which bind to one of the PDIs. ∆H is the change in enthalpy for the
intermolecular interactions. V0 is an active cell volume, which considers the volume of the
ITC cell and the volume increased by titration. The dissociation constant is denoted as Kd.
The total concentrations of P5 Cys55/58/190/193Ala mutant and PDIs are displayed as
[P5 Cys55/58/190/193Ala]t and [PDIs]t, respectively, at any given time (t).
2.6. Preparation of Reduced and Denatured RNase A
Reduced and denatured RNase A was prepared as previously described [44,48]. Briefly,
RNase A was dissolved in buffer consisting of 50 mM Tris-HCl (pH 8.0), 6 M GdnHCl, and
40 mM DTT and incubated for 2 h at 25 ◦C. The incubated sample was dialyzed three times
with a large excess of 10 mM HCl to remove the denaturing and reducing reagents.
2.7. Gel-Shift Assay of RNase A Oxidation
Gel-shift assays were performed by optimizing the method reported in previous
studies [44,49]. Reduced and denatured RNase A (16 µM) was incubated with refolding
buffer containing 50 mM HEPES (pH 7.2), 150 mM NaCl, 1 mM reduced glutathione (GSH),
and 0.2 mM oxidized glutathione (GSSG), in the absence/presence of 1 µM PDIs or 0.5 µM
P5 and other PDIs. At selected time points, the reaction was quenched, and free thiols were
modified by addition of Laemmli 4 × sodium dodecyl sulfate (SDS)-sample buffer [32]
containing 10 mM methoxy-polyethylene glycol maleimide MW 2000 (mPEG-mal 2k; Cat.
No. ME-020MA; NOF America Corporation, White Plains, NY, USA). Modified samples
were separated by nonreducing 14% SDS-polyacrylamide gel electrophoresis (PAGE) using
a WIDE RANGE gel (Nacalai Tesque). Proteins were stained with Coomassie Brilliant Blue
G250 (Nacalai Tesque) [50]. Band intensities were analyzed using ImageJ/Fiji [46] and
Microsoft Excel. The relative band intensities of fully reduced form (R) and fully oxidized
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form (N/4SS) on SDS-PAGE gels were calculated compared with the band intensity of
negative controls (0) and positive controls (N) in the same gels, respectively.
2.8. RNase A Reactivation Assay
Reactivation assays were performed by optimizing the method reported in previous
studies [44,48,51]. Reduced and denatured RNase A (16 µM) was incubated with refolding
buffer containing 50 mM HEPES (pH 7.2), 150 mM NaCl, 1 mM GSH, and 0.2 mM GSSG,
in the absence/presence of 1 µM PDIs or 0.5 µM P5 and 0.5 µM other PDIs. At selected
time points, 50 µL aliquots were taken from the refolding mixture and immediately diluted
with 150 µL reaction buffer containing 50 mM HEPES (pH 7.2), 150 mM NaCl, and 0.8 mM
cytidine 2′,3′-cyclic monophosphate (cCMP) monosodium salt (final concentration of
cCMP = 0.6 mM; Cat. No. C9630; Sigma-Aldrich). The absorbance at 284 nm was measured
with a V-730BIO spectrophotometer (JASCO Corp., Tokyo, Japan). The reaction rate of
cCMP hydrolysis was calculated from the linear increase in the absorbance. The ratio of
refolded RNase A was calculated from the relative rate compared with the reaction rate of
native RNase A.
2.9. GAPDH Aggregation Assay
GAPDH was dissolved in buffer comprising 50 mM Tris-HCl (pH 8.0), 3 M GdnHCl,
and 3 mM DTT and incubated overnight at 4 ◦C. Aggregation assays were performed
by optimizing the method reported in previous studies [52–54]. Reduced and denatured
GAPDH (125 µM) was diluted 125-fold (final concentration of GAPDH = 1 µM) in a
chaperone assay buffer containing 50 mM HEPES (pH 7.2) and 150 mM NaCl and incubated
at 20 ◦C in the absence/presence of 5 µM PDIs or 2.5 µM P5 and 2.5 µM other PDIs.
Aggregation of GAPDH was monitored by 90◦ light scattering at 620 nm on a FP-8300
spectrofluorometer (JASCO Corp). Data were analyzed by Spectra Manager software
(JASCO Corp) and Microsoft Excel. The initial rate of GAPDH aggregation was calculated
from the increase in fluorescence intensity during the initial 60 s.
2.10. Statistical Analysis
Statistical analysis of the results of PDIs combinations and calculated arithmetic
means of the results of P5 alone and PDIs alone was performed by Microsoft Excel using a
two-tailed t-test, and p < 0.05 was considered significant.
3. Results
3.1. PDI and ERp72 Form Non-Covalent Complexes with P5
To investigate complex formation between P5 and other PDIs via non-covalent inter-
actions, we used the far-western dot blot method [44,45,55,56] (Figure 1b,c). Briefly, we
fixed known concentrations of reduced forms of PDIs as prey proteins onto a nitrocellulose
membrane. After blocking and treatment with 0.2 µM reduced form of P5 as bait protein,
the membrane was washed, and bait proteins (P5) bound to the prey proteins were de-
tected using anti-P5 antiserum. There was no signal for P5 bound to the secretory proteins
lactoferrin and albumin, but positive signals were observed for the ER stress sensor IRE1,
which is regulated by P5 [36,39] (Figure 1b). As demonstrated in previous studies [21], this
method could be applied for in vitro interactome analysis of P5 to identify partners binding
via non-covalent interactions. We therefore examined whether non-covalent binding occurs
between P5 and other PDIs using reduced PDIs for far-western dot blot analysis and found
that PDIs bound to P5 with different affinities (Figure 1c). Quantification of chemilumi-
nescence signals with defined amounts of prey proteins on membranes demonstrated
that PDI and ERp72 were bound more tightly to P5 than ERp57 and ERp46 (Figure 1d).
To quantitatively estimate the binding affinity of these intermolecular interactions in so-
lution, isothermal titration calorimetry (ITC) experiments were performed (Figure 1e,f).
P5 in the syringe was titrated into a solution containing ERp72 or PDI in the cell. The
ITC thermograms of the interaction between P5 and ERp72/PDI indicated an exothermic
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reaction, suggesting that a negative enthalpy change contributed thermodynamically to
the formation of complexes through intermolecular electrostatic and polar interactions
(Figure 1e,f). Indeed, the ITC analyses revealed that the change in enthalpy (∆H) of P5
binding to PDI and ERp72 was −4.4 ± 0.2 and −10.7 ± 0.8 kcal mol−1, respectively. The
change in entropy (∆S) was positive for PDI-P5 (T∆S = 3.4 ± 0.3 kcal mol−1); however, it
was negative for PDI-ERp72 (T∆S = −3.3 ± 0.5 kcal mol−1). The n value indicating the
binding stoichiometry was 0.10 ± 0.0 for both binding systems, which suggests that the
same number of ERp72 and PDI molecules bind to P5 based on a one-site binding model.
It was noteworthy that the affinity of P5 for PDI was similar to that for ERp72, based on the
change in Gibbs free energy (∆G) of −7.5 ± 0.2 to −7.8 ± 0.1 kcal mol−1 and a dissociation
constant (Kd) ranging from 2.4 ± 0.3 to 4.1 ± 0.8 µM. Thus, we concluded that both ERp72
and PDI bind non-covalently to P5.
3.2. P5 and PDI Act in Concert to Synergistically Accelerate Oxidative Folding
To estimate the impact of PDI/ERp72 on P5 enzymatic function, we next investigated
whether the combination of P5-PDI or P5-ERp72 affects the efficiency of disulfide bond
introduction. Ribonuclease A (RNase A) containing four disulfide bonds was used as a
model substrate. Reduced and denatured RNase A was incubated with 1 µM PDIs alone,
and free thiol(s) in RNase A were modified with methoxy-polyethylene glycol maleimide
MW 2000 (mPEG-mal 2k). The slower migration of RNase A modified by mPEG-mal 2k can
be used to separate redox states by SDS-PAGE according to the number of modifications
via free thiol(s) (Figure 2). In the presence of P5, reduced RNase A (R) disappeared at 3 min,
and fully-oxidized RNase A (N/4SS) was observed at 5 min during an early folding step
(Figure 2a). However, fully-oxidized RNase A (N/4SS) was hardly visible at 5 min in the
presence of PDI (Figure 2b,c). Consistent with our previous results [14,36], P5 introduced
disulfide bonds into clients more rapidly than PDI and ERp72.
To investigate whether the intermolecular interactions between PDIs are related to
enzymatic efficiency, we performed a series of combination experiments. The catalytic
efficiency was evaluated by comparing the theoretical values (calculated arithmetic means
of the results of each 1 µM PDIs alone from Figure S1) with the experimental values of the
combinations at half concentrations (0.5 µM P5 + 0.5 µM other PDIs). If intermolecular
interactions affect the catalytic efficiency, there should be a significant difference between
theoretical and experimental values. In the case of the P5-PDI combination, the band
corresponding to reduced RNase A disappeared within 3 min, and oxidized RNase A
was visible at 5 min (Figure 2b; 12 P5+
1
2 PDI). Quantitative analysis showed that, with
this combination, the band intensity of reduced RNase A at both 3 min and 5 min was
significantly lower than the theoretical value (Figure 2d; 12 P5+
1
2 PDI and Calc.), implying
synergistic introduction of disulfide bonds by P5-PDI during the initial step. In the case of
the P5-ERp72 combination, the band corresponding to reduced RNase A also disappeared
within 3 min, but the effect appeared to be similar to that of P5 alone and ERp72 alone
(Figure 2c). In contrast to the P5-PDI combination, quantitative analysis demonstrated that
the P5-ERp72 combination had no impact on disulfide bond formation compared with the
theoretical value (Figure 2g; 12 P5+
1
2 ERp72 and Calc.).
To determine whether oxidized RNase A folds into a native conformation, we mea-
sured the hydrolysis activity of refolded RNase A using cytidine 2′,3′-cyclic monophosphate
(cCMP) as a substrate. Compared with the theoretical value calculated using the results of
P5 alone and PDI alone (Figure 3a), the ratio of refolded RNase A catalyzed by the combina-
tion of PDI-P5 was markedly higher than the theoretical value (Figure 3c; 12 P5+
1
2 PDI and
Calc.), implying synergistic acceleration of oxidative folding by the P5-PDI combination.
On the other hand, the P5-ERp72 combination had no impact on disulfide bond formation
compared with the theoretical value (Figure 3b,d).




Figure 2. Disulfide bond formation in RNase A catalyzed by P5 in concert with PDI/ERp72. (a–c) 
RNase A oxidation assay in the presence of P5, PDI, ERp72, P5/PDI, and P5/ERp72. Reduced and 
denatured RNase A (16 µM) was incubated without PDIs or with 1 µM P5 (a); 1 µM PDI or 0.5 µM 
P5 and 0.5 µM PDI (b); or 1 µM ERp72 or 0.5 µM P5 and 0.5 µM ERp72 (c). In addition to reduced 
RNase A, an equal amount of native RNase A was loaded into lane N as a positive control. R, fully 
reduced form of RNase A; 1SS, 2SS, 3SS, intermediates with one, two, or three disulfide bonds, 
respectively; N/4SS, mixture of the native form of RNase A and the fully oxidized form possessing 
four disulfide bonds; non-sp, non-specifically modified band. (d–g) Quantification of the relative 
band intensities of the fully reduced form (R: d,f) and fully oxidized form (N/4SS: e,g) following 
SDS-PAGE analysis (a–c). Error bars indicate the means ± SEM of three independent experiments. 
½P5+½PDI: results for 0.5 µM P5 and 0.5 µM PDI; ½P5+½ERp72, results for 0.5 µM P5 and 0.5 µM 
ERp72; no PDIs, results without PDIs; Calc., calculated arithmetic means of the results of P5 alone 
and PDIs alone (see Figure S1). ** p < 0.01, statistical significance between the means of ½P5+½PDIs 
and Calc. using a two-tailed t-test. 
To investigate whether the intermolecular interactions between PDIs are related to 
enzymatic efficiency, we performed a series of combination experiments. The catalytic ef-
ficiency was evaluated by comparing the theoretical values (calculated arithmetic means 
of the results of each 1 µM PDIs alone from Figure S1) with the experimental values of the 
combinations at half concentrations (0.5 µM P5 + 0.5 µM other PDIs). If intermolecular 
interactions affect the catalytic efficiency, there should be a significant difference between 
Figure 2. Disulfide bond formation in RNase A catalyzed by P5 in concert with PDI/ERp72.
(a–c) RNase A oxidation assay in the presence of P5, PDI, ERp72, P5/PDI, and P5/ERp72. Re-
duced and denatured RNase A (16 µM) was incubated without PDIs or with 1 µM P5 (a); 1 µM PDI
or 0.5 µM P5 and 0.5 µM PDI (b); or 1 µM ERp72 or 0.5 µM P5 and 0.5 µM ERp72 (c). In addition to
reduced RNase A, an equal amount of native RNase A was l aded into l ne N as a positive control.
R, fully reduced form of RNase A; 1SS, 2SS, 3SS, intermediates with one, two, or three disulfide
bonds, respectively; N/4SS, mixture of the native form of RNase A and the fully oxidized form
possessing four disulfide bonds; non-sp, non-specifically modified band. (d–g) Quantification of
the relative band intensities of the fully reduced form (R: d,f) and fully oxidized form (N/4SS: e,g)
following SDS-PAGE analysis (a–c). Error bars indicate the means ± SEM of three independent
experiments. 12 P5+
1




2 ERp72, results for 0.5 µM P5
and 0.5 µM ERp72; no PDIs, results without PDIs; Calc., lculated arithmetic means of the results
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(a–d) Reduced and denatured RNase A (16 µM) was incubated without PDIs (no PDIs), with 1.0 µM
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2 ERp72) (d), and cCMP hydrolysis by refolded
RNase A was measured. The ratio of refolded RNase A was calculated from the relative rate compare
with the reaction rate of native RNase A. Error bars indicate the means ± SEM of three independent
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3.3. P5 Acts in Concert with ERp72 to Strongly Inhibit Client Aggregation
Next, we examined chaperone activity using reduced/denatured GAPDH aggrega-
tion assays (Figures S2 and 4). As a control, non-reduced and folded GAPDH (Native
GAPDH) did not exhibit light scattering, whereas reduced/denatured GAPDH without
PDIs (noPDIs) showed a significant increase in light scattering intensity (Figure 4a). The
result indicated that P5 induces reduced/denatured GAPDH to aggregate (Figure S2),
while PDI or ERp72 inhibits aggregation of GAPDH (Figure S2a,b and Figure 4b,d). We
subsequently calculated theoretical profiles using arithmetic means (Calc.). The light scat-
tering profile of P5 in concert with PDI ( 12 P5+
1
2 PDI) was almost the same as the theoretical
profile, suggesting that, despite the complex formation, PDI did not affect the property of
P5 to induce GAPDH aggregation.
Importantly, the GAPDH aggregation was strongly inhibited by P5 in concert with
ERp72 ( 12 P5+
1
2 ERp72) compared with the arithmetic mean (Figure 4c). Of note, the initial
aggregation rate was also significantly decreased compared with the arithmetic mean
calculated from the initial rates of P5 and ERp72 (Figure 4d). This result suggests that
P5-induced GAPDH aggregation is suppressed by ERp72 and that the P5 chaperone activity
is increased by forming a complex with ERp72.
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4. Discussion
In this study, we showed that P5 non-covalently interacts with PDI (Figure 1) to
enhance the efficiency of disulfide bond formation and isomerization (Figures 3 and 4).
Previous studies demonstrated that P5 binds to PDIs via covalent interactions in cultured
cells [42] and that the plant P5 homolog promotes oxidative folding by transfer of disulfide
bonds to the plant ERp57 homolog [44]. These findings suggest that disulfide-bonded
complexes between PDIs promote oxidative client folding, but knowledge on non-covalent
complexes between PDIs remains limited. Some studies on non-covalent PDI complexes
have been reported; the oxidized form of PDI forms non-covalent homodimers in an
unfolded substrate-dependent manner to promote oxidative folding [32], and PDI also
binds to P4HA and MTP to facilitate other functions of the partners by forming hetero-
complexes [12,33–35]. Our current results demonstrate that hetero-complex formation
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between P5 and PDI via non-covalent interaction plays a key role in stimulating enzymatic
activity (Figure 5).
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Figure 5. Schematic representation of the efficient productive folding system resulting from non-covalent interaction
between P5, PDI, and ERp72. The combination of P5 and PDI enhances the efficiency of disulfide bond formation and
isomerization during the oxidative folding reaction. Meanwhile, the combination of P5 and ERp72 efficiently inhibits
aggregation of reduced and denatured substrates in the initial folding step. Straight and curved arrows indicate the
progression of disulfide b d formation and isomerization during the oxidative folding reaction and the progression of
misfolding nd aggregation of nfold d substrates, respectively.
ur previous works demonstrated that, while disulfide bonds are rapidly and promis-
cuously introduced by P5/ERp46 during the early stage of oxidative protein folding, PDI
efficiently proofreads non-native disulfide bonds during the later stage [10,11]. As a result
of the synergistic effects of these enzymes, oxidative protein folding can be greatly acceler-
ated. The present work provides another mechanistic implication: P5 and PDI can work
cooperatively to accelerate oxidative protein folding by forming a non-covalent complex
(Figure 1). Further biophysical and cell biological experiments are awaited to elucidate
molecular and physiological details of the functional interplays between P5 and PDI.
Regarding chaperone function, the efficiency was increased by P5-ERp72 combination
(Figures 4 and 5). During the catalysis of initial oxidative folding process, P5 appears to
gain easy access to a random coiled aggregation-prone conformation [14,36]. Nevertheless,
only P5 displayed lower chaperone activity against reduced/denatured client (Figure S2)
but relatively higher chaperone activity against folded client [36]. When interpreted in
terms of client folding, the P5 chaperone function seems to be enhanced by forming a
complex with ERp72 during the initial folding step. The efficiency of chaperones can be
enhanced when they interact with each other, not only in the ER [57,58], but also in other
cellular compartments [59–64].
5. Conclusions
In conclusion, we identified P5-PDI and P5-ERp72 as functional hetero-complexes
between PDIs that accelerate client folding. We propose a complex formation-driven
modulation mechanism of enzymatic and chaperone activities that has implications for
anti-aggregation, productive folding, and misfolding-related pathology.
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